AAV vector mediated gone therapy of Fabry knockout mice.

被引:0
|
作者
Shimada, T
Zenri, K
Ogawa, K
Takahashi, H
Hirai, Y
Seino, Y
Fukuda, Y
机构
[1] Nippon Med Sch, Dept Biochem, Tokyo 113, Japan
[2] Nippon Med Sch, Dept Internal Med, Tokyo 113, Japan
[3] Nippon Med Sch, Dept Pathol, Tokyo 113, Japan
关键词
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
2686
引用
收藏
页码:626 / 626
页数:1
相关论文
共 50 条
  • [21] Delivery of osteoprotegerin (OPG)Using an adeno-associated virus (AAV) gene therapy vector reverse established Osteopenia in ovariectomized (OVX) mice.
    Morony, S
    Bolon, B
    Carter, C
    Geng, Z
    Daris, M
    Kostenuik, PJ
    Sheng, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S165 - S165
  • [22] Innervation of dentin and pulp in galanin knockout mice.
    Matthews, B
    Wanachantararak, S
    Sirimaharaj, V
    Tilly, G
    Wynick, D
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A396 - A396
  • [23] Zinc kinetics in metallothionein-knockout mice.
    Wastney, ME
    House, WA
    FASEB JOURNAL, 1999, 13 (04): : A214 - A214
  • [24] Glucose tolerance in metallothionein-knockout mice.
    Wastney, ME
    House, WA
    FASEB JOURNAL, 2000, 14 (04): : A512 - A512
  • [25] AAV9 mediated gene therapy of MLD model mice
    Miyake, Noriko
    Miyake, Koichi
    Sakai, Atsushi
    Yamamoto, Motoko
    Endo, Ayumi
    Suzuki, Hidenori
    Shimada, Takashi
    HUMAN GENE THERAPY, 2012, 23 (10) : A50 - A50
  • [26] Immune Response to AAV Vector Capsid and Assessment of Eligibility for AAV Mediated Gene Therapy for Duchenne Muscular Dystrophy
    Saha, Madhurima
    MOLECULAR THERAPY, 2022, 30 (04) : 76 - 76
  • [27] Impairment of neuropeptide Y (NPY)-mediated angiogenesis in Y2 receptor knockout mice.
    Lee, EW
    Grant, D
    Zukowska, Z
    FASEB JOURNAL, 2002, 16 (04): : A89 - A89
  • [28] AAV Vector-Mediated In Vivo Reprogramming of Various Cell Types in Adult Mice
    Sens, Elena
    Mosteiro, Lluc
    Wilkening, Stefan
    Schmidt, Manfred
    Serrano, Manuel
    Grimm, Dirk
    MOLECULAR THERAPY, 2015, 23 : S121 - S121
  • [29] Defective tumor necrosis factor-α-mediated liver failure in acidic sphingomyelinase knockout mice.
    Colell, A
    Mari, M
    Morales, A
    Coll, O
    García-Ruiz, C
    Fernandez-Checa, JC
    HEPATOLOGY, 2002, 36 (04) : 299A - 299A
  • [30] Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease
    Wang, Gensheng
    Young, Sarah P.
    Bali, Deeksha
    Hutt, Julie
    Li, Songtao
    Benson, Janet
    Koeberl, Dwight D.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2014, 1 : 14018